sigvotatug vedotin Clinical Trials (2026): 5 Studies for Carcinoma, Non-Small Cell Lung & Non-Small Cell Lung Cancer

Where to Participate: All sigvotatug vedotin Trial Sites in the U.S. (178 sites across 25 states)

Every actively recruiting sigvotatug vedotintrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

sigvotatug vedotin clinical trials at a glance: phase × recruitment status

Recruiting sigvotatug vedotin clinical trials (3)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

sigvotatug vedotin clinical trials by indication

sigvotatug vedotin pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All sigvotatug vedotin trials (5)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

sigvotatug vedotin clinical trials: frequently asked questions

How many sigvotatug vedotin clinical trials are there?

5 sigvotatug vedotin clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 3 are actively recruiting participants. 1 is marked completed.

Are sigvotatug vedotin clinical trials recruiting in 2026?

Yes — 3 sigvotatug vedotin trials are actively recruiting in 2026, with 178 U.S. sites across 25 states. See the recruiting trials and the per-state site list further down this page.

What conditions is sigvotatug vedotin being studied for?

sigvotatug vedotin is being studied for Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Carcinoma, Non-Small-Cell Lung and 12 more. The trials are grouped by indication on this page.

What phase is sigvotatug vedotin in?

sigvotatug vedotin clinical trials span 2 Phase 3, 2 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors sigvotatug vedotin clinical trials?

The lead sponsor across the most sigvotatug vedotin trials is Seagen, a wholly owned subsidiary of Pfizer, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming sigvotatug vedotinas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.